The likely impact of trade-related aspects of intellectual property rights (TRIPS) in Mozambique : the case of anti-malarial drugs

Simple item page
dc.contributor.advisorRehnberg, Clasen_ZA
dc.contributor.authorMatsinhe, Tania Romanaen_ZA
dc.date.accessioned2014-09-08T14:26:29Z
dc.date.available2014-09-08T14:26:29Z
dc.date.issued2002en_ZA
dc.descriptionBibliography: leaves 94-99.en_ZA
dc.description.abstractSince 1994, there has been a lot of attention drawn on the World Trade Organization (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) as the most important international instrument ever negotiated in this area. TRIPS establishes minimum universal standards in all areas of intellectual property and the intention is to implement these standards globally through a strong enforcement mechanism established in WTO. These standards affect pharmaceuticals, which many countries had previously excluded from patent protection in order to produce drugs at reduced prices and hence contribute to the improvement of public health. But now any Member State must comply with these minimum standards since failure to do so will result to the WTO dispute settlement system. No extensive review of the practical implications of the TRIPS Agreement has taken place at the global and national levels. The main objective of this paper is to examine the likely impact of this agreement on anti-malarial drugs in Mozambique. Given the persistence of the malaria epidemic in the country and the resistance to the drugs being utilized for this disease there is an acknowledged need for a new drug to eradicate the problem. The problem is that this new drug is likely to be under patent and this country has relied on generic drugs for all its existence and being a Member of the WTO Agreement they now have to wait until patents on the required drugs have expired or be submissive to the more expensive original brand. To accomplish this objective and to ascertain the end result of the above situation, past experiences were a major tool. By reviewing experiences of less developed countries in relation to patent protection and pharmaceuticals, some conclusions were made possible. In order to narrow down the conclusions drawn from these country experiences, a study was done in the Mozambican public sector by reviewing and analyzing the existing laws and regulations pertaining to pharmaceuticals and patent protection. This was done through questionnaires and interviews of the main stakeholders in this area. With this information the researcher was able to describe where Mozambique stands in relation to patents and how this might affect the pharmaceutical industry as a Member of the WTO agreement in the long run. This study therefore, relies heavily on secondary data.en_ZA
dc.identifier.apacitationMatsinhe, T. R. (2002). <i>The likely impact of trade-related aspects of intellectual property rights (TRIPS) in Mozambique : the case of anti-malarial drugs</i>. (Thesis). University of Cape Town ,Faculty of Commerce ,School of Economics. Retrieved from http://hdl.handle.net/11427/6990en_ZA
dc.identifier.chicagocitationMatsinhe, Tania Romana. <i>"The likely impact of trade-related aspects of intellectual property rights (TRIPS) in Mozambique : the case of anti-malarial drugs."</i> Thesis., University of Cape Town ,Faculty of Commerce ,School of Economics, 2002. http://hdl.handle.net/11427/6990en_ZA
dc.identifier.citationMatsinhe, T. 2002. The likely impact of trade-related aspects of intellectual property rights (TRIPS) in Mozambique : the case of anti-malarial drugs. University of Cape Town.en_ZA
dc.identifier.ris TY - Thesis / Dissertation AU - Matsinhe, Tania Romana AB - Since 1994, there has been a lot of attention drawn on the World Trade Organization (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) as the most important international instrument ever negotiated in this area. TRIPS establishes minimum universal standards in all areas of intellectual property and the intention is to implement these standards globally through a strong enforcement mechanism established in WTO. These standards affect pharmaceuticals, which many countries had previously excluded from patent protection in order to produce drugs at reduced prices and hence contribute to the improvement of public health. But now any Member State must comply with these minimum standards since failure to do so will result to the WTO dispute settlement system. No extensive review of the practical implications of the TRIPS Agreement has taken place at the global and national levels. The main objective of this paper is to examine the likely impact of this agreement on anti-malarial drugs in Mozambique. Given the persistence of the malaria epidemic in the country and the resistance to the drugs being utilized for this disease there is an acknowledged need for a new drug to eradicate the problem. The problem is that this new drug is likely to be under patent and this country has relied on generic drugs for all its existence and being a Member of the WTO Agreement they now have to wait until patents on the required drugs have expired or be submissive to the more expensive original brand. To accomplish this objective and to ascertain the end result of the above situation, past experiences were a major tool. By reviewing experiences of less developed countries in relation to patent protection and pharmaceuticals, some conclusions were made possible. In order to narrow down the conclusions drawn from these country experiences, a study was done in the Mozambican public sector by reviewing and analyzing the existing laws and regulations pertaining to pharmaceuticals and patent protection. This was done through questionnaires and interviews of the main stakeholders in this area. With this information the researcher was able to describe where Mozambique stands in relation to patents and how this might affect the pharmaceutical industry as a Member of the WTO agreement in the long run. This study therefore, relies heavily on secondary data. DA - 2002 DB - OpenUCT DP - University of Cape Town LK - https://open.uct.ac.za PB - University of Cape Town PY - 2002 T1 - The likely impact of trade-related aspects of intellectual property rights (TRIPS) in Mozambique : the case of anti-malarial drugs TI - The likely impact of trade-related aspects of intellectual property rights (TRIPS) in Mozambique : the case of anti-malarial drugs UR - http://hdl.handle.net/11427/6990 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/6990
dc.identifier.vancouvercitationMatsinhe TR. The likely impact of trade-related aspects of intellectual property rights (TRIPS) in Mozambique : the case of anti-malarial drugs. [Thesis]. University of Cape Town ,Faculty of Commerce ,School of Economics, 2002 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/6990en_ZA
dc.language.isoengen_ZA
dc.publisher.departmentSchool of Economicsen_ZA
dc.publisher.facultyFaculty of Commerceen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.subject.otherHealth Economicsen_ZA
dc.titleThe likely impact of trade-related aspects of intellectual property rights (TRIPS) in Mozambique : the case of anti-malarial drugsen_ZA
dc.typeMaster Thesis
dc.type.qualificationlevelMasters
dc.type.qualificationnameMSocScen_ZA
uct.type.filetypeText
uct.type.filetypeImage
uct.type.publicationResearchen_ZA
uct.type.resourceThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
thesis_com_2002_matsinhe_tr (1).pdf
Size:
8.96 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Masters